Literature DB >> 24814856

Ataxia with oculomotor apraxia type 2 fibroblasts exhibit increased susceptibility to oxidative DNA damage.

Ricardo H Roda1, Carlo Rinaldi2, Rajat Singh3, Alice B Schindler2, Craig Blackstone4.   

Abstract

Ataxia with oculomotor apraxia type 2 (AOA2) is an autosomal recessive cerebellar ataxia associated with mutations in SETX, which encodes the senataxin protein, a DNA/RNA helicase. We describe the clinical phenotype and molecular characterization of a Colombian AOA2 patient who is compound heterozygous for a c.994 C>T (p.R332W) missense mutation in exon 7 and a c.6848_6851delCAGA (p.T2283KfsX32) frameshift deletion in SETX exon 21. Immunocytochemistry of patient-derived fibroblasts revealed a normal cellular distribution of the senataxin protein, suggesting that these mutations do not lead to loss or mis-localization of the protein, but rather that aberrant function of senataxin underlies the disease pathogenesis. Furthermore, we used the alkaline comet assay to demonstrate that patient-derived fibroblast cells exhibit an increased susceptibility to oxidative DNA damage. This assay provides a novel and additional means to establish pathogenicity of SETX mutations.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AOA2; Autosomal recessive cerebellar ataxia; DNA repair; Helicase; Senataxin

Mesh:

Substances:

Year:  2014        PMID: 24814856      PMCID: PMC4127342          DOI: 10.1016/j.jocn.2013.11.048

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  29 in total

1.  Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study.

Authors:  C Criscuolo; L Chessa; S Di Giandomenico; P Mancini; F Saccà; G S Grieco; M Piane; F Barbieri; G De Michele; S Banfi; F Pierelli; N Rizzuto; F M Santorelli; L Gallosti; A Filla; C Casali
Journal:  Neurology       Date:  2006-04-25       Impact factor: 9.910

2.  Novel mutations in the senataxin DNA/RNA helicase domain in ataxia with oculomotor apraxia 2.

Authors:  Brent L Fogel; Susan Perlman
Journal:  Neurology       Date:  2006-12-12       Impact factor: 9.910

3.  Senataxin, the yeast Sen1p orthologue: characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease.

Authors:  Ying-Zhang Chen; Sayed H Hashemi; Susan K Anderson; Yongzhao Huang; Maria-Ceu Moreira; David R Lynch; Ian A Glass; Phillip F Chance; Craig L Bennett
Journal:  Neurobiol Dis       Date:  2006-04-27       Impact factor: 5.996

Review 4.  New autosomal recessive cerebellar ataxias with oculomotor apraxia.

Authors:  Isabelle Le Ber; Alexis Brice; Alexandra Dürr
Journal:  Curr Neurol Neurosci Rep       Date:  2005-09       Impact factor: 5.081

5.  Mutations in senataxin responsible for Quebec cluster of ataxia with neuropathy.

Authors:  Antoine Duquette; Katel Roddier; Julia McNabb-Baltar; Isabelle Gosselin; Anik St-Denis; Marie-Josée Dicaire; Lina Loisel; Damian Labuda; Luc Marchand; Jean Mathieu; Jean-Pierre Bouchard; Bernard Brais
Journal:  Ann Neurol       Date:  2005-03       Impact factor: 10.422

6.  Autosomal recessive ataxia with peripheral neuropathy and elevated AFP: novel mutations in SETX.

Authors:  T Asaka; H Yokoji; J Ito; K Yamaguchi; A Matsushima
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

7.  Ataxia with oculomotor apraxia type 2: a clinical and genetic study of 19 patients.

Authors:  M Tazir; L Ali-Pacha; A M'Zahem; J P Delaunoy; M Fritsch; S Nouioua; T Benhassine; S Assami; D Grid; J M Vallat; A Hamri; M Koenig
Journal:  J Neurol Sci       Date:  2009-01-11       Impact factor: 3.181

8.  Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients.

Authors:  M Anheim; B Monga; M Fleury; P Charles; C Barbot; M Salih; J P Delaunoy; M Fritsch; L Arning; M Synofzik; L Schöls; J Sequeiros; C Goizet; C Marelli; I Le Ber; J Koht; J Gazulla; J De Bleecker; M Mukhtar; N Drouot; L Ali-Pacha; T Benhassine; M Chbicheb; A M'Zahem; A Hamri; B Chabrol; J Pouget; R Murphy; M Watanabe; P Coutinho; M Tazir; A Durr; A Brice; C Tranchant; M Koenig
Journal:  Brain       Date:  2009-08-20       Impact factor: 13.501

9.  Clinical and molecular findings of ataxia with oculomotor apraxia type 2 in 4 families.

Authors:  Mathieu Anheim; Marie-Celine Fleury; Jerome Franques; Maria-Ceu Moreira; Jean-Pierre Delaunoy; Dominique Stoppa-Lyonnet; Michel Koenig; Christine Tranchant
Journal:  Arch Neurol       Date:  2008-07

10.  Senataxin, defective in ataxia oculomotor apraxia type 2, is involved in the defense against oxidative DNA damage.

Authors:  Amila Suraweera; Olivier J Becherel; Philip Chen; Natalie Rundle; Rick Woods; Jun Nakamura; Magtouf Gatei; Chiara Criscuolo; Alessandro Filla; Luciana Chessa; Markus Fusser; Bernd Epe; Nuri Gueven; Martin F Lavin
Journal:  J Cell Biol       Date:  2007-06-11       Impact factor: 10.539

View more
  8 in total

1.  Disruption of Spermatogenesis and Infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2).

Authors:  Olivier J Becherel; Brent L Fogel; Scott I Zeitlin; Hemamali Samaratunga; Jessica Greaney; Hayden Homer; Martin F Lavin
Journal:  Cerebellum       Date:  2019-06       Impact factor: 3.847

2.  A new model to study neurodegeneration in ataxia oculomotor apraxia type 2.

Authors:  Olivier J Becherel; Jane Sun; Abrey J Yeo; Sam Nayler; Brent L Fogel; Fuying Gao; Giovanni Coppola; Chiara Criscuolo; Giuseppe De Michele; Ernst Wolvetang; Martin F Lavin
Journal:  Hum Mol Genet       Date:  2015-07-30       Impact factor: 6.150

3.  Biallelic mutations in SNX14 cause a syndromic form of cerebellar atrophy and lysosome-autophagosome dysfunction.

Authors:  Naiara Akizu; Vincent Cantagrel; Maha S Zaki; Lihadh Al-Gazali; Xin Wang; Rasim Ozgur Rosti; Esra Dikoglu; Antoinette Bernabe Gelot; Basak Rosti; Keith K Vaux; Eric M Scott; Jennifer L Silhavy; Jana Schroth; Brett Copeland; Ashleigh E Schaffer; Philip L S M Gordts; Jeffrey D Esko; Matthew D Buschman; Seth J Field; Gennaro Napolitano; Ghada M Abdel-Salam; R Koksal Ozgul; Mahmut Samil Sagıroglu; Matloob Azam; Samira Ismail; Mona Aglan; Laila Selim; Iman G Mahmoud; Sawsan Abdel-Hadi; Amera El Badawy; Abdelrahim A Sadek; Faezeh Mojahedi; Hulya Kayserili; Amira Masri; Laila Bastaki; Samia Temtamy; Ulrich Müller; Isabelle Desguerre; Jean-Laurent Casanova; Ali Dursun; Murat Gunel; Stacey B Gabriel; Pascale de Lonlay; Joseph G Gleeson
Journal:  Nat Genet       Date:  2015-04-06       Impact factor: 38.330

4.  Tight expression regulation of senataxin, linked to motor neuron disease and ataxia, is required to avert cell-cycle block and nucleolus disassembly.

Authors:  Craig L Bennett; Bryce L Sopher; Albert R La Spada
Journal:  Heliyon       Date:  2020-06-13

5.  Lysosomal abnormalities in hereditary spastic paraplegia types SPG15 and SPG11.

Authors:  Benoît Renvoisé; Jaerak Chang; Rajat Singh; Sayuri Yonekawa; Edmond J FitzGibbon; Ami Mankodi; Adeline Vanderver; Alice Schindler; Camilo Toro; William A Gahl; Don J Mahuran; Craig Blackstone; Tyler Mark Pierson
Journal:  Ann Clin Transl Neurol       Date:  2014-06-01       Impact factor: 4.511

6.  Senataxin resolves RNA:DNA hybrids forming at DNA double-strand breaks to prevent translocations.

Authors:  Sarah Cohen; Nadine Puget; Yea-Lih Lin; Thomas Clouaire; Marion Aguirrebengoa; Vincent Rocher; Philippe Pasero; Yvan Canitrot; Gaëlle Legube
Journal:  Nat Commun       Date:  2018-02-07       Impact factor: 14.919

7.  Integrated genome and transcriptome analyses reveal the mechanism of genome instability in ataxia with oculomotor apraxia 2.

Authors:  Radhakrishnan Kanagaraj; Richard Mitter; Theodoros Kantidakis; Matthew M Edwards; Anaid Benitez; Probir Chakravarty; Beiyuan Fu; Olivier Becherel; Fengtang Yang; Martin F Lavin; Amnon Koren; Aengus Stewart; Stephen C West
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-25       Impact factor: 12.779

8.  Molecular Characterization of Portuguese Patients with Hereditary Cerebellar Ataxia.

Authors:  Mariana Santos; Joana Damásio; Susana Carmona; João Luís Neto; Nadia Dehghani; Leonor Correia Guedes; Clara Barbot; José Barros; José Brás; Jorge Sequeiros; Rita Guerreiro
Journal:  Cells       Date:  2022-03-12       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.